Available Until 4/20/2024

A Call to Action: Dedicated Medication Safety Transformation in the Perioperative Setting

NOTE: If you attended this live CE activity AND received CE credit (i.e. a Pharmacist or Pharmacy Technician CE statement of credit with ACPE UAN 0221-9999-21-277-L05-P/T), you are not allowed to also receive credit for this home-study on-demand web activity.

Activity Description

In the perioperative setting, medication errors frequently occur in all phases of perioperative care and are a common cause of morbidity and mortality. When medication errors occur, they are often the result of the complexity of care combined with the fast-paced and fragmented nature of perioperative service delivery.

This activity will focus on the daily challenges of ensuring medication safety in the high-risk perioperative or procedural setting, highlighting the national aggregate findings and practice gaps identified using ISMP's Medication Safety Self Assessment for Perioperative Settings, and providing highlights of the draft consensus best practice statements developed at ISMP's national perioperative summit. This program will discuss challenges faced during the implementation of best practices and advancing technologies in the perioperative setting, as well as resources and plans for addressing these obstacles.

Learning Objectives

The intended audience includes: Pharmacists and Pharmacy Technicians. Upon completion of this activity, participants will be able to:

  • Identify current national safety challenges with medication management in U.S. perioperative and procedural settings.
  • Highlight the practice risks discovered by inpatient and ambulatory surgical and procedural sites participating in the ISMP Medication Safety Self Assessment for Perioperative Settings.
  • Examine the ISMP best practice guidance draft, action plans, and resources developed for hospitals and ambulatory surgical centers to begin the transformation towards meaningful medication safety improvements.
  • Recognize first-hand barriers and challenges faced during the early adoption and implementation of safe medication practices in perioperative and procedural settings.


Behind the Closed Doors: The Status of Medication Safety in Perioperative Settings
Julie Boytim, DNP, CRNA, Performance Anesthesia Services

Understanding the National Aggregate Results from the 2021 Perioperative Assessment
Rita K. Jew, PharmD, MBA, BCPPS, FASHP, President, ISMP

Advancing Technologies for the Safe Use of Medication in the Perioperative Setting: The Future is Now
Gee Mathen, Director, Pharmacy Clinical Applications & Technical Services, Texas Children's Hospital

CE Accreditation

Release Date: April 20, 2022
Expiration Date: April 20, 2024

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-277-H05-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.


ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Julie Boytim, Rita K. Jew and Gee Mathen do not have any relevant commercial and/or financial relationships to disclose.


This CE activity is supported by an educational grant from Pfizer.


The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.